In its effort to change how code stacking is used to bill for certain genetic and molecular tests, Palmetto GBA announced changes to its Molecular Diagnostic Services Program (MolDx). Earlier this month, the Medicare carrier announced that the effective date for claim submissions under MolDx would move from March 1, 2012, to May 1, 2012. […]
To access this post, you must purchase The Dark Report.